Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 21

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 21
---
 with its affiliates, to beneficially own a 
 number of shares of Common Stock which would exceed the 9.99% Ownership Cap. Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 9.99% Ownership Cap percentage up to   
 19.99%. The address of Stonepine Capital, LP is 919 NW Bond Street, Suite 204, Bend, OR 97703.                                                                                                                                             |

| (12) | The number of shares of Common Stock beneficially owned prior to this offering includes 165,543 shares of Common Stock                                                                                                                     
 underlying warrants owned by this Selling Stockholder. Under the terms of such warrants, the holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a 
 number of shares of Common Stock which would exceed the 4.99% Ownership Cap. Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 4.99% Ownership Cap percentage up to   
 19.99%. The number of shares beneficially owned prior to this offering does not include 63,628 shares of Common Stock underlying such warrants as a result of the Ownership Cap and the 61 days’ advance notice provision. The address of  
 Joseph F. Lawler is 2110 Ranch Road 620 S, #341732, Lakeway, TX 78734.                                                                                                                                                                     |

| (13) | The number of shares of Common Stock beneficially owned prior to this offering includes 323,764 shares of Common Stock                                                                                                                         
 underlying warrants owned by this Selling Stockholder. Under the terms of such warrants, the holder may not exercise the warrants to the extent such exercise would cause such holder, together with its affiliates, to beneficially own a     
 number of shares of Common Stock which would exceed the 9.99% Ownership Cap. Upon 61 days’ advance written notice to us, the holder of such warrants may from time to time increase or decrease the 9.99% Ownership Cap percentage up to       
 19.99%. The number of shares beneficially owned prior to this offering does not include 397,614 shares of Common Stock underlying such warrants as a result of the Ownership Cap and the 61 days’ advance notice provision. The address for SS 
 Pharma LLC is c/o Cerity Partners, P.O. Box 10188 #38984, Newark, New